Package insert for Pfizer's Voriconazole dry powder oral suspension (Vfend) detailing composition, dosage, storage and safety information.
This leaflet provides comprehensive information on Voriconazole dry powder for oral suspension, marketed under the brand name Vfend (威凡®). It describes the active ingredient (voriconazole), excipients, physical appearance, and the intended therapeutic indications for invasive fungal infections in adults and children.
The document also outlines preparation instructions, recommended dosing regimens for treatment and prophylaxis, storage conditions, contraindications, drug‑drug interactions, adverse reactions, and pharmacokinetic properties. Packaging details, shelf‑life, and regulatory identifiers are included at the end of the insert. This manual is written in Chinese.
| Active ingredient | Voriconazole |
|---|---|
| Dry powder amount per bottle | 45 g |
| Reconstituted concentration | 40 mg/ml |
| Storage temperature (dry powder) | 2 °C – 8 °C (refrigerated) |
| Shelf life (dry powder) | 24 months |
| Shelf life (reconstituted suspension) | 14 days |
Add 23 ml of water twice to the 100 ml bottle, shake vigorously for 1 minute, close the child‑safety cap, attach the bottle adaptor, and label the bottle with the expiration date. The final suspension volume is 75 ml (usable volume 70 ml).